DBV Technologies S.A. - American Depositary Shares (DBVT)
14.86
-0.00 (-0.00%)
NASDAQ· Last Trade: Jul 17th, 7:23 AM EDT
Detailed Quote
Previous Close
14.86
Open
-
Bid
15.41
Ask
15.62
Day's Range
N/A - N/A
52 Week Range
8.510 - 26.18
Volume
4,716
Market Cap
818.73M
PE Ratio (TTM)
-18.35
EPS (TTM)
-0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
281,927
Chart
About DBV Technologies S.A. - American Depositary Shares (DBVT)
Dbv Technologies is a biopharmaceutical company focused on developing innovative therapies for patients with food allergies, particularly peanut allergies. Utilizing its proprietary Systemic Immunotherapy platform, the company aims to create treatments that help desensitize individuals to allergens, ultimately enhancing their quality of life and reducing the risk of severe allergic reactions. By leveraging advanced medical technology and a rigorous clinical development approach, Dbv Technologies strives to bring novel, breakthrough solutions to the field of immunotherapy for food allergies. Read More
DBV Technologies (NASDAQ:DBVT) said it is continuing preparations for a planned third-quarter 2026 Biologics License Application submission for its VIASKIN Peanut Patch in children ages 4 through 7, while also building commercial infrastructure ahead of a potential U.S. launch.
On a conference call
